These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29280825)

  • 1. Tuberculosis Infection Despite Isoniazid Prophylaxis in a Patient With Psoriatic Arthritis Treated With Etanercept.
    Giollo A; Carletto A; Tonetta S; Del Bravo P; Rossini M
    J Clin Rheumatol; 2019 Aug; 25(5):e74-e75. PubMed ID: 29280825
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment with etanercept monotherapy in a hemodialyzed patient with moderate-to-severe plaque-type psoriasis and psoriatic arthritis.
    Babino G; Esposito M; Bianchi L; Giunta A
    G Ital Dermatol Venereol; 2018 Dec; 153(6):882-884. PubMed ID: 29144096
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocomplementemic Urticarial Vasculitis Syndrome Possibly Secondary to Etanercept Use.
    Fadahunsi AW; Garcia-Rosell M; Pattanaik D
    J Clin Rheumatol; 2015 Aug; 21(5):274-5. PubMed ID: 26203836
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept in the treatment of psoriatic arthritis.
    Puig L; López-Ferrer A; Laiz A
    Actas Dermosifiliogr; 2015 May; 106(4):252-9. PubMed ID: 25455504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Study of Patients on Etanercept Therapy for Rheumatic Diseases in Patients With Chronic Hepatitis C Virus.
    Gandhi NP; Manadan AM; Block JA
    J Clin Rheumatol; 2017 Aug; 23(5):252-257. PubMed ID: 28700530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid subcutaneous desensitization for treatment of hypersensitivity reactions to etanercept in two patients with positive basophil activation test.
    de la Varga Martínez R; Gutiérrez Fernández D; Foncubierta Fernández A; Andrés García JA; Medina Varo F
    Allergol Int; 2017 Apr; 66(2):357-359. PubMed ID: 27780662
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious?
    Sánchez-Moya AI; Dauden E
    Int J Dermatol; 2014 Mar; 53(3):e211-2. PubMed ID: 23786208
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatotoxicity associated with etanercept in psoriatic arthritis.
    Leak AM; Rincon-Aznar B
    J Rheumatol; 2008 Nov; 35(11):2286-7. PubMed ID: 19004062
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis After Renal Transplant.
    Barbouch S; Hajji M; Helal I; Ounissi M; Bacha MM; Ben Hamida F; Abderrahim E; Ben Abdallah T
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):200-203. PubMed ID: 28260468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
    Kitamura G; Mehr N; Anderson N; Sirichotiratana M
    Dermatol Online J; 2009 Feb; 15(2):11. PubMed ID: 19336028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections.
    Aggarwal R; Manadan AM; Poliyedath A; Sequeira W; Block JA
    J Rheumatol; 2009 May; 36(5):914-7. PubMed ID: 19332623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis.
    Aboulafia DM; Bundow D; Wilske K; Ochs UI
    Mayo Clin Proc; 2000 Oct; 75(10):1093-8. PubMed ID: 11040859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting.
    Conti A; Piaserico S; Gisondi P; Odorici G; Galdo G; Lasagni C; Pellacani G
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28547750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.
    Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB
    Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy.
    Wu KY; Yang DH; Chen CW
    Ann Saudi Med; 2015; 35(3):260-2. PubMed ID: 26409803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Paradoxical Induction of Crohn’s Disease Following Treatment of Psoriatic Arthritis With Etanercept.
    Forouzandeh M; Vazquez T; Nouri K; Forouzandeh B
    J Drugs Dermatol; 2019 Aug; 18(8):832-834. PubMed ID: 31424717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole.
    Camargo JF; Yakoub D; Cho-Vega JH
    Mycopathologia; 2015 Oct; 180(3-4):187-92. PubMed ID: 26112998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolones for the treatment of latent
    Silva JT; San-Juan R; Fernández-Ruiz M; Aguado JM
    World J Gastroenterol; 2019 Jul; 25(26):3291-3298. PubMed ID: 31341356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An enlarging solitary mass in an asymptomatic patient.
    Seif F; Montenegro H
    Am J Med; 2011 Jul; 124(7):611-3. PubMed ID: 21683829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.